The results suggest no statistically significant differences after up to 48 months and borderline significant differences in favour of HVGIC sealants after 60 months (RR 0.29; 95% CI: 0.09–0.95; p = 0.04 / RD -0.07; 95% CI: -0.14, -0.01).
← all phrases
“borderline significant”
Sighted at
p=0.09
In the literature
There was borderline significant ( p = 0.04) association between factor loading and social value subscale-3 scores.
63.3 ± 2.3 years (Median: 65.0 years), which was borderline significant ( p = 0.04).
Modelling associations between evening cortisol level and letter search speed in the sample with complete information on all covariates ( n = 1093) found a similar borderline significant result ( β = −0.063, SE = 0.03, p = .04; Table 4 , Model 1).
They also include studies that found either borderline significant reduction in CDI (P=0.04, [ 53 ]) or no statistical significance through a reduction in either high-risk drugs or total antimicrobial usage in healthcare settings (respectively, P=0.0597 and P=0.0823, [ 52 ]).
The main effect of ISI on the size of LFP responses was not significant (F(1,868) = 3.31, p = 0.07), and even the interaction between ISI and the group of rats was only borderline significant (F(1,866) = 4.35, p = 0.04).
3C ), borderline significant correlation in cohort 2 (r = 0.24, P = 0.04) ( Fig. 3D ) and positive correlation in cohort 3 (r = 0.63, P = 0.004) ( Fig. 3E ).
For TNF-α, there is a borderline significant inverse relationship with fRHI, with an estimated difference of –0.55 ± 0.26 ( p = 0.040).
This equates to a borderline significant Hc association with midperipheral loss versus Lc association with pericentral loss ( P = 0.04).
In the total sample, the fully adjusted model (Model 3) yielded a borderline significant association (β = 0.123, 95%CI 0.00 to 0.24, p = 0.04) (Table 4 ).
The direct effect of METSIR on the outcome variable NAFLD was significant (β = 0.06, P < 0.001), and there was a borderline significant negative effect of HDL-C on NAFLD (β = -0.01, P = 0.04).
2009 ) comparing pit and fissure sealings with HVGIC applied by press-finger technique versus the conventional application of resin-based sealants and found no significant differences for both for follow-ups up to 48 months “[...] and borderline significant differences in favour of HVGIC sealants after 60 months (RR 0.29; 95% CI: 0.09–0.95; p = 0.04/RD -0.07; 95% CI: -0.14, -0.01) [...]” (Mickenautsch and Yengopal 2016 ).
According to the BAT median cut-off at the baseline, no statistically significant hazard ratio (HR) was found for either PFS or OS, except for TPS1, which had a borderline significant ( p = 0.04) OS risk reduction (HR = 0.33, 95% CI: 0.12–0.95) for TPS1 > 144 ng/mL ( Table 3 ).
Over the one‐year follow‐up period, a significant increase in the TCNS was observed in the high median HbA1c ARV group ( P = 0.001), along with borderline significant decreases in peroneal and tibial CMAPs in the low median HbA1c ARV group from baseline to the one‐year follow‐up ( P = 0.04, and P = 0.03, respectively).
The corollary analysis including only USA–based trials returned a borderline significant small effect (SMD −0.24 (95%CI −0.48, −0.01) p = 0.04).
In the multivariate data meta-analysis (fixed effects), there was a borderline significant association between sarcopenia and OS (fixed effects, HR = 1.20, 95% CI: 1.01, 1.44, P = 0.04, I 2 = 43%; k = 5; n = 831).
4 ) but an Egger's regression was borderline significant (intercept 1.55, t -value = 2.07, d.f. = 69, P = 0.04).
Exercise and Nexrutine modulate the cytokine profile of TRAMP mice Of the 32 cytokines measured in week 4 and week 20 samples, control mice had borderline significant changes only in IL-13 (p = 0.04; Fig 6 ).
SUVmaxpre was found to be a borderline significant independent predictor of local recurrence ( p = 0.040) (Fig. 3 ).
Among women, a borderline significant finding occurred in adjusted models at treatment completion where those with myosteatosis scored higher in physical QOL scores (β 19.12; p = 0.04).
A borderline significant interaction was detected ( p = 0.04), with an increased concentration of mercury measured in the feces of mice exposed to MeHg HD and SeMet concomitantly ( Figure 2 ). 2.3.
The staging of kidney function at referral was: Stage 1 in 0.7% of participants, Stage 2 in 4.2%, Stage 3 in 37.5%, Stage 4 in 30.8% and Stage 5 in 26.8%; with a borderline significant difference by gender ( p = 0.04).
The CIs barely exclude 1, indicating a borderline significant result ( P = 0.04).
Although a borderline significant reduction in triglycerides (TG) levels was noted (MD = −0.24, 95% CI −0.47 to −0.01, P = 0.04), this finding displayed considerable heterogeneity.
Per-protocol analysis (12 patients and 14 patients in the fluvoxamine and placebo group, respectively) of the same outcomes showed no significant differences except for a borderline significant difference in the general fatigue domain of the MFI in favour of the placebo group (p = 0.04).